Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
1.600
0.00 (0.00%)
At close: Sep 12, 2025, 4:00 PM EDT
1.620
+0.020 (1.25%)
After-hours: Sep 12, 2025, 7:58 PM EDT
Hoth Therapeutics Market Cap
Hoth Therapeutics has a market cap or net worth of $21.21 million as of September 12, 2025. Its market cap has increased by 320.94% in one year.
Market Cap
21.21M
Enterprise Value
12.22M
1-Year Change
320.94%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since February 15, 2019, Hoth Therapeutics's market cap has decreased from $80.39M to $21.21M, a decrease of -73.61%. That is a compound annual growth rate of -18.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 21.21M | 268.28% |
| Dec 31, 2024 | 5.76M | -7.96% |
| Dec 29, 2023 | 6.26M | -38.29% |
| Dec 30, 2022 | 10.14M | -35.89% |
| Dec 31, 2021 | 15.82M | -50.32% |
| Dec 31, 2020 | 31.85M | -49.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |